Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study

[1] Song P(2019)Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis Lancet Glob Health Elsevier BV 7 e1020-e1030

[2] Rudan D(1991)Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population Int J Epidemiol Oxford University Press (OUP) 20 384-392

[3] Zhu Y(2009)Three-year follow-up and event rates in the international REduction of Atherothrombosis for continued health registry Eur Heart J 30 2318-2326

[4] Fowkes FJI(2018)Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome Eur J Vasc Endovasc Surg 55 529-536

[5] Rahimi K(2017)ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Societ

[6] Fowkes FGR(1954)Surgical treatment of peripheral circulation disorders Helv Chir Acta 21 499-533

[7] Fowkes FG(2014)Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline Ann Intern Med American College of Physicians 160 339-343

[8] Housley E(2016)Interpretation of the evidence for the efficacy and safety of statin therapy Lancet 388 2532-2561

[9] Cawood EH(2010)Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 919-933

[10] Macintyre CC(2013)Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding J Am Coll Cardiol 62 2261-2273

[1] Song P(2019)Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis Lancet Glob Health Elsevier BV 7 e1020-e1030

[2] Rudan D(1991)Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population Int J Epidemiol Oxford University Press (OUP) 20 384-392

[3] Zhu Y(2009)Three-year follow-up and event rates in the international REduction of Atherothrombosis for continued health registry Eur Heart J 30 2318-2326

[4] Fowkes FJI(2018)Ten year mortality in different peripheral arterial disease stages: a population based observational study on outcome Eur J Vasc Endovasc Surg 55 529-536

[5] Rahimi K(2017)ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO) The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Societ

[6] Fowkes FGR(1954)Surgical treatment of peripheral circulation disorders Helv Chir Acta 21 499-533

[7] Fowkes FG(2014)Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline Ann Intern Med American College of Physicians 160 339-343

[8] Housley E(2016)Interpretation of the evidence for the efficacy and safety of statin therapy Lancet 388 2532-2561

[9] Cawood EH(2010)Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 919-933

[10] Macintyre CC(2013)Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding J Am Coll Cardiol 62 2261-2273